Cargando…
Guillain‐Barré syndrome presenting with facial diplegia following COVID‐19 vaccination in two patients
In March 2020, the WHO declared COVID‐19 to be a global pandemic and since December 2020, millions of vaccines have been administered. To date, cases of Guillain‐Barré syndrome (GBS) following a COVID vaccine (Pfizer, Johnson & Johnson, Janssen, AstraZeneca) have been reported. A 61-year-old wom...
Autores principales: | Kanabar, Gorande, Wilkinson, Phil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522664/ https://www.ncbi.nlm.nih.gov/pubmed/34649856 http://dx.doi.org/10.1136/bcr-2021-244527 |
Ejemplares similares
-
Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine
Publicado: (2022) -
Isolated facial diplegia: A rare presentation of Guillain‐Barre syndrome
por: Sardar, Sundus, et al.
Publicado: (2021) -
Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report
por: Rossetti, Arianna, et al.
Publicado: (2021) -
Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report
por: Zubair, Adeel S, et al.
Publicado: (2022) -
Facial diplegia with hyperreflexia-a mild Guillain-Barre Syndrome variant, to treat or not to treat?
por: Sethi, Nitin K, et al.
Publicado: (2007)